H.R.366 - Breast Implant Accountability Act105th Congress (1997-1998)
|Sponsor:||Rep. Traficant, James A., Jr. [D-OH-17] (Introduced 01/07/1997)|
|Committees:||House - Commerce|
|Latest Action:||01/22/1997 Referred to the Subcommittee on Health and Environment.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: H.R.366 — 105th Congress (1997-1998)All Bill Information (Except Text)
Introduced in House (01/07/1997)
Breast Implant Accountability Act - Requires each manufacturer of a breast implant to notify each individual with a silicone gel or saline implant implanted before 1994 that the manufacturer will pay for removal and will allow the recipient to select the physician and hospital or center for the removal.
Directs the Secretary of Health and Human Services to conduct or contract for research on the physiological, neurological, and immunological effects of chemicals found in, or used in the manufacture of, breast implants. Requires inclusion in the research of individuals who are included in a specified class action suit in Alabama, if they volunteer for the research.
Prohibits: (1) physicians from doing silicone breast implants without patient execution of a consent form prescribed by the Secretary and from refusing the treatment of a patient because the patient has received a breast implant; (2) grants to an organ procurement organization if the organization has allowed an individual who has a breast implant to donate an organ; and (3) licensing of any blood collection entity if the entity receives blood from such an individual.